Conversely, the expression of Trem2 and other NASH-associated genes, such as Gpnmb, Tnf, and Col1a1, were downregulated when mice were treated with Elafibranor. The gene discussed is TREM2; the disease is metabolic dysfunction-associated steatohepatitis.